# LinkedIn Post — Detailed Caption

**A cited answer is not automatically an evidence-grade answer.**

For clinical AI, the question is no longer just whether a system can retrieve literature and display references. The harder question is whether it can help a clinician understand the *strength*, *fit*, and *limitations* of the evidence supporting a specific answer.

That is the problem OpenEvidence’s **EvidenceGrade** is designed to address.

According to OpenEvidence, EvidenceGrade is a real-time, GRADE-inspired assessment of evidence strength for applicable clinical AI answers. Its ambition is not merely to show that a claim has sources. It is to characterize the body of evidence behind that claim in a way that makes confidence—and uncertainty—more legible at the point of use.

The distinction matters.

A response may include several credible citations and still rest on evidence that is indirect, imprecise, inconsistent, poorly matched to the clinical situation, or outweighed by stronger evidence elsewhere. Citation count is therefore a poor proxy for decision readiness.

**How the stated framework works**

EvidenceGrade describes an assessment at two levels.

First, it evaluates each retrieved paper across three dimensions:

• **Quality:** Is the study design appropriate for the question being answered?  
• **Certainty:** How reliable and precise are the results?  
• **Relevance:** How directly does the evidence map to the patient population, intervention or exposure, comparator, outcome, and clinical context?

Second, it synthesizes the body of evidence. The approach may account for evidence from guidelines and systematic reviews, study-design ceilings, and classic GRADE-like factors that can increase or decrease confidence—for example, consistency, large effects, dose response, bias, imprecision, and indirectness.

The resulting signal is reported as a grade from **A to D**, with plus/minus modifiers, or **U: Unable to Grade**.

That final option may be one of the most important design choices. In high-stakes clinical settings, a system should be able to say that evidence cannot be responsibly graded rather than presenting a polished but unwarranted confidence signal. A visible “U” is often more useful than a falsely decisive letter.

**Why this is promising**

Evidence-aware clinical AI could improve the conversation around trust. It gives users a structured way to move from “the system found papers” to “what is the support for this answer, and how much should that support influence a decision?”

If implemented and calibrated well, this kind of framework could help clinical teams:

• Identify when an answer is grounded in a stronger versus weaker body of evidence  
• Separate well-supported recommendations from areas of unresolved uncertainty  
• Make source evaluation more visible in the workflow  
• Encourage appropriate clinical review instead of citation-based reassurance  
• Create a more auditable path from an AI-generated claim back to the underlying literature

**But a grade should not be treated as a verdict.**

Real-time evidence grading remains difficult because the final signal depends on a chain of context-sensitive judgments.

A grade can only reflect the evidence that was retrieved. If pivotal studies, relevant subgroup analyses, conflicting trials, or newer findings are absent from the retrieval set, the output may look more definitive than the underlying search supports.

Relevance is equally challenging. The same study can be highly informative for one patient population or care setting and only weakly applicable to another. A letter grade cannot substitute for the clinical context that determines whether evidence transfers to the patient in front of the clinician.

There is also a communication problem: one letter is efficient, but it can compress different sources of uncertainty into a single symbol. Limited confidence due to bias is not the same as limited confidence due to imprecision, indirectness, inconsistency, or simply insufficient evidence. Users need enough explanation to understand *why* a grade is limited.

Finally, any automated GRADE-inspired method should be independently validated and calibrated against expert clinical-methodology review. The relevant standard is not whether the system produces an intuitively plausible score. It is whether the score is reliable, reproducible, transparent, clinically meaningful, and appropriately calibrated across conditions, populations, evidence types, and changing literature.

**The practical takeaway**

EvidenceGrade points toward a more mature model for clinical AI: not an AI that projects certainty, but one that exposes the structure of uncertainty.

The right question to ask an AI system is not simply:

*“Does it provide citations?”*

It is:

*“Can I see what evidence supports this answer, how strong that evidence is, why it received that assessment, and where the uncertainty remains?”*

That is the difference between evidence retrieval and evidence-aware decision support.

Swipe through the carousel for the workflow, the meaning of the grades, the limitations, and the question every clinical-AI team should be asking.

**What would you need to see before you would trust an evidence-grade signal inside a clinical workflow?**

#ClinicalAI #EvidenceBasedMedicine #MedicalAI #HealthAI #Pharma #MedicalAffairs #ClinicalDecisionSupport #DigitalHealth #AIPharmaXchange

---
**Source:** OpenEvidence, *EvidenceGrade* — https://www.openevidence.com/evidence-grade

**Editorial note:** The description of EvidenceGrade’s workflow and outputs is source-grounded. The discussion of retrieval dependency, context-sensitive relevance, compressed uncertainty, and independent calibration represents analytical considerations rather than confirmed defects.
